Matthew Reiser Patton

Follow

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Triazolopyridinyl compounds as kinase inhibitors
- Patent number 12,110,290
- Issue date Oct 8, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyridinyl compounds as kinase inhibitors
- Patent number 11,767,322
- Issue date Sep 26, 2023
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
- Publication number 20240425505
- Publication date Dec 26, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20240190890
- Publication date Jun 13, 2024
- Bristol-Myers Squibb Company
- Xirui Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
- Publication number 20240109888
- Publication date Apr 4, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
- Publication number 20220119388
- Publication date Apr 21, 2022
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY